Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Freeze-dried FMT capsules for relapsing C. difficile infection
NCT02399618Phase 1Unknown
- Sponsor
- Jinling Hospital
- Start
- Mar 2015
- Primary completion
- Sep 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Fecal Microbiota Transplantation Capsule in Clostridium difficile infection (CDI), sponsored by Jinling Hospital. Primary endpoints: Safety at 3 months and Efficacy at 3 months. Status: unknown.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT02399618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02399618.